×
About 12,620 results

ALLMedicine™ Adenovirus Center

Research & Reviews  4,730 results

Insulin-like growth factor 1 gene transfer for sporadic Alzheimer's disease: New eviden...
https://doi.org/10.1002/hipo.23379
Hippocampus Zappa Villar MF, López Hanotte J et. al.

Jul 30th, 2021 - Sporadic Alzheimer's disease (sAD) is the most prevalent neurodegenerative disorder with no cure. Patients typically suffer from cognitive impairment imprinted by irreversible neocortex and hippocampal degeneration with overt synaptic and neuron d...

Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression dur...
https://doi.org/10.1093/jpp/rgab051
The Journal of Pharmacy and Pharmacology; Kamioka H, Edaki K et. al.

Jul 28th, 2021 - Epithelial-mesenchymal transition (EMT) plays a role in cancer metastasis as well as in drug resistance through various mechanisms, including increased drug efflux mediated by P-glycoprotein (P-gp). In this study, we investigated the activation me...

see more →

Guidelines  1 results

Community acquired respiratory virus infections in cancer patients-Guideline on diagnos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125955
European Journal of Cancer (Oxford, England : 1990); von Lilienfeld-Toal M, Berger A et. al.

Sep 30th, 2016 - Community acquired viruses (CRVs) may cause severe disease in cancer patients. Thus, efforts should be made to diagnose CRV rapidly and manage CRV infections accordingly. A panel of 18 clinicians from the Infectious Diseases Working Party of the G...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  150 results

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
https://clinicaltrials.gov/ct2/show/NCT03710876

Apr 28th, 2020 - TITLE: A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination with Celecoxib and Gemcitabine in Patients with ...

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
https://clinicaltrials.gov/ct2/show/NCT03313128

Apr 9th, 2020 - This is a controlled cohort study to assess the effect of improved sanitation on oral rotavirus vaccine performance in low-income urban neighbourhoods of Maputo, Mozambique. The specific hypotheses are that: (1) access to improved sanitation is as...

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Prote...
https://clinicaltrials.gov/ct2/show/NCT03307915

Mar 10th, 2020 - The primary purpose of this study is to assess safety/tolerability of 2 different prime/boost regimens containing adenovirus serotype 26 (Ad26).Mos4.HIV, Modified Vaccinia Ankara (MVA) -Mosaic or adjuvanted Mosaic and Clade C gp140 in Human immuno...

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma
https://clinicaltrials.gov/ct2/show/NCT03284268

Feb 25th, 2020 - Phase I study, single site, open label with dose escalation, for evaluate safety and the oncolitic Adenovirus VCN-01 activity in patients with refractory retinoblastoma.

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
https://clinicaltrials.gov/ct2/show/NCT03225989

Feb 25th, 2020 - The trial is a Phase I/II trial evaluating the effect of LOAd703 in patients with pancreatic cancer, biliary cancer, ovarian cancer and colorectal cancer. LOAd703 is an oncolytic adenovirus serotype 5/35 encoding immunostimulatory transgenes: TMZ-...

see more →

News  153 results

Study: J&J Vaccine Less Effective Against Variants
https://www.medscape.com/viewarticle/955172

Jul 21st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new study says the one-dose Johnson & Johnson vaccine provides less protection against the Delta and Lamba variants than against the original CO...

Chance That COVID-19 Vaccines Are Gene Therapy? 'Zero'
https://www.medscape.com/viewarticle/954955

Jul 16th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. There are lots of unfounded fears about the COVID-19 vaccines floating around, and one of the most pervasive is the idea that these new shots aren...

Gap Between Sputnik V COVID-19 Shots Can Be Up to 180 Days: Russia's RDIF
https://www.medscape.com/viewarticle/954503

Jul 12th, 2021 - MOSCOW (Reuters) - The gap between the two shots of the Sputnik V coronavirus vaccine can be extended up to 180 days and it will remain effective, the Russian Direct Investment Fund (RDIF) said on Friday. An official at the RDIF, which markets the...

COVID-19 Vaccines Safe, Effective for Patients With Migraine
https://www.medscape.com/viewarticle/953589

Jun 23rd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. It is safe for patients with migraine to receive any of the COVID-19 vaccines without concern about the vaccination interfering with their migrain...

CVST Risk Still Higher With COVID-19 Than With AZ, J&J Vaccination
https://www.medscape.com/viewarticle/952890

Jun 10th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Another study has suggested that rates of cerebral venous sinus thrombosis (CVST) are much higher among patients with COVID-19 than among persons ...

see more →

Patient Education  2 results see all →